Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers-Reference-Cited by-同舟云学术

Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers

Published:2017-01 Issue:1 Volume:16 Page:16-21
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Ruscitti Piero,Cipriani Paola,Ciccia Francesco,Masedu Francesco,Liakouli Vasiliki,Carubbi Francesco,Berardicurti Onorina,Guggino Giuliana,Di Benedetto Paola,Di Bartolomeo Salvatore,Valenti Marco,Triolo Giovanni,Giacomelli Roberto

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis;Bode;Arthritis Res Ther,2012

2. Hemophagocytic lymphohistiocytosis (HLH) and related disorders;Filipovich;Hematology Am Soc Hematol Educ Program,2009

3. Adult haemophagocytic syndrome;Ramos-Casals;Lancet,2014

4. Macrophage activation syndrome;Ravelli;Hematol Oncol Clin North Am,2015

5. Macrophage activation syndrome in the era of biologic therapy;Grom;Nat Rev Rheumatol,2016

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Still’s Disease Onset in Older Adults: Clinical Features, Diagnosis, and Management;Drugs & Aging;2024-08-03

2. Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus;Autoimmunity Reviews;2024-07

3. The immunoregulatory effects of total glucosides of peony in autoimmune diseases;Journal of Leukocyte Biology;2024-04-16

4. Cluster analysis defines four groups of Japanese patients with adult-onset Still’s disease;Modern Rheumatology;2024-03-06

5. The latest advances in the use of biological DMARDs to treat Still’s disease;Expert Opinion on Biological Therapy;2024-02